Skip to main content
SpringerLink
Log in

Effect of chemotherapy on T-lymphocyte subsets in B-cell proliferative disorders

  • Original Articles
  • Published:
Blut Aims and scope Submit manuscript

Summary

The T-cell subset distribution and the activity markers of 41 patients with multiple Myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy were repeatedly analysed using monoclonal antibodies (T3, T4, T8, anti-TAC, anti DR) and rosetting techniques. In myeloma and macroglobulinaemia the relative and absolute numbers of T4+ cells were diminished while the absolute number of T8+ cells was not decreased. No significant difference between stage I and III of the myeloma disease was seen. The diminished number of T4+ cells in myeloma was partly due to the effect of chemotherapy. Chemotherapy-induced lymphopenia resulted in a drop of circulating T4+ cells and an inverted T4/T8 cell ratio. Untreated patients with myeloma were not significantly different from patients with benign gammopathy. Patients with macroglobulinaemia differed from patients with myeloma as they had an increased absolute T8 cell count and a significantly elevated percentage of TAC+ (= IL 2 receptor expressing) cells. In macroglobulinaemia chemotherapy affected also the T8+ cell subset. Thus, patients with macroglobulinaemia, but not with myeloma appear to have activated T8+ cells in their circulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Broder S, Humphrey R, Durm M, Blackman M, Meade B, Goldman C, Strober W, Waldmann T (1975) Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma. Role of suppressor cells. N Engl J Med 293: 887–892

    Google Scholar 

  2. Durie B, Salmon S (1975) A clinical staging system for multiple myeloma. Cancer 36: 842–854

    Google Scholar 

  3. Gershon R (1974) T-cell control of antibody production. Contemp Top Immunobiol 3: 1–40

    Google Scholar 

  4. Gonzalez M, San Miguel J, Caballero D, Lopez-Borrasca A (1983) Helper/suppressor T-cell subpopulations in benign paraproteinaemia. Br J Haematol 54: 318–320

    Google Scholar 

  5. Hoover R, Hickmann S, Gebel H, Rebbe N, Lynch R (1981) Expansion of Fc-receptor-bearing T-lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma. J Clin Invest 67: 308–311

    Google Scholar 

  6. Ludwig H, Fritz E (1982) Lymphocyte subpopulations in multiple myeloma: expansion of suppressor T-cells as defined by monoclonal antibodies. Abstracts of the 19th International Society of Hematology Meeting in Budapest, Hungary, p 178

  7. Mellstedt H, Holm G, Petterson D, Björkholm M, Johannson B, Lindemalm C, Peest D, Ahre A (1982) T-cells in monoclonal gammopathies. Scand J Haematol 29: 57–64

    Google Scholar 

  8. Mills KHG, Worman CP, Cawley JC (1982) T-cell subsets in B-chronic lymphocytic leukemia (CLL). Br J Haematol 50: 710–712

    Google Scholar 

  9. Mills KHG, Cawley JC (1983) Abnormal monoclonal antibody-defined helper/suppressor T-cell subpopulations in multiple myeloma: relationship to treatment and clinical stage. Br J Haematol 53: 271–275

    Google Scholar 

  10. Miyawaki T, Yachie A, Uwadana N, Ohzeki S, Nagaoki T, Taniguchi N (1982) Functional significance of TAC antigen expressed on activated human T-lymphocytes: TAC antigen interacts with T-cell growth factor in cellular proliferation. J Immunol 129: 2474–2478

    Google Scholar 

  11. Nagel JE, Francis JC, Adler WH (1981) Enumeration of T-lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol 127: 2086–2088

    Google Scholar 

  12. Oken MM, Kay NE (1981) T-cell subpopulations in multiple myeloma: Correlation with clinical disease status. Br J Haematol 49: 629–634

    Google Scholar 

  13. Pichler WJ, Knapp W (1977) Receptors for IgM-coated erythrocytes on chronic lymphatic leukemia cells. J Immunol 118: 1010–1015

    Google Scholar 

  14. Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-TAC) reactive with activated and functionally mature human T-cells. I. Production of anti-TAC monoclonal antibody and distribution of TAC (+) cells. J Immunol 126: 1393–1397

    Google Scholar 

  15. Waldmann TA, Broder S, Blease RM, Durm M, Blackman M, Strober W (1974) Role of suppressor T-cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet 2: 609–613

    Google Scholar 

  16. Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HJ, Kunkel HG (1980) Peripheral blood Ia-positive T-cells. Increases in certain diseases and after immunization. J Exp Med 151: 91–100

    Google Scholar 

Download references

Author information

Author notes

  1. W. J. Pichler

    Present address: Institut für Klinische Immunologie, Inselspital, CH-3010, Bern, Switzerland

Authors and Affiliations

  1. Abteilung Immunologie und Transfusionsmedizin, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Straße 8, D-3000, Hannover 61

    C. A. Emmendörffer & W. J. Pichler

Authors
  1. C. A. Emmendörffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. J. Pichler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Emmendörffer, C.A., Pichler, W.J. Effect of chemotherapy on T-lymphocyte subsets in B-cell proliferative disorders. Blut 50, 149–156 (1985). https://doi.org/10.1007/BF00320071

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320071

Key words

Search

Navigation